Press Releases

29 September 2023 -- London, UK -- FlyPharma Europe will welcome Mr Florian Tursky, the Austrian state secretary, to the conference on 10 October, where he will deliver an opening speech. He will join a host of expert industry speakers from both pharma and cargo sectors

26 September 2023 -- Massachusetts, US -- Revvity unveils its groundbreaking Pin-point base editing platform reagents, providing researchers with unparalleled access to implement the advanced gene editing technique in their preclinical laboratories

26 September 2023 -- Molndal, Sweden -- Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticity research

26 September 2023 -- Cambridge, UK -- Start Codon, a life science and healthcare venture-building fund, is pleased to invite life sciences leaders, entrepreneurs and investors from across the life science and biotech industries to attend their Innovation Showcase 2023

26 September 2023 -- Cambridge, UK -- Evonetix, the Company developing semiconductor scale technology to improve access to gene synthesis, announces the introduction of new branding to align with its vision to ‘Redefine possible’ through the development and commercialisation of its benchtop semiconductor gene synthesis platform

25 September 2023 -- Nottingham, UK -- Sygnature Discovery and UBE Corporation have begun a collaboration on a Hit-to-Lead programme to identify SHP2 degraders

25 September 2023 -- Cambridge, UK -- Optibrium, a leading developer of software and AI solutions for drug discovery, launched the latest version of its drug discovery platform, StarDrop 7.5, introducing a powerful module for drug metabolism prediction

21 September 2023 -- London, UK -- Benchling launches its inaugural 2023 State of Tech in Biopharma report. The report surveyed 300 R&D and IT experts from biopharma companies large and small to do a first-ever investigation into biopharma’s use of an enabling tech stack.

21 September 2023 -- Nottingham, UK -- A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive disorder (MDD)

19 September 2023 -- Pennsylvania, US -- Mural Health Technologies, a next-generation clinical trial participant management platform, announced that it has raised $8 million in seed funding, led by Bessemer Venture Partners, with participation from Virtue VC, Operator Partners, Arkitect Ventures, Correlation Ventures and Project Mayhem Ventures.

19 September 2023 -- Uppsala, Sweden -- Olink Holding AB announced the introduction of Olink Target 48 Mouse Cytokine Panel, a validated multiplexed protein panel that offers a detailed view of the murine immune system, enabling in-depth disease modelling, longitudinal studies and translational research.

14 September 2023 -- Barcelona, UK -- Researchers at VHIO, led by Dr Cristina Saura, head of the VHIO Breast Cancer Group and the Breast Unit at Vall d'Hebron University Hospital, and Dr Ana Vivancos, head of VHIO's Genomics laboratory, has shown for the first time that breast milk from breast cancer patients contains tumour DNA, known as circulating tumour DNA (ctDNA).